Earnings Feed
Start Free
Home/Filings/4/0000899243-22-009770
4//SEC Filing

Whitney Rebecca Ann 4

Accession 0000899243-22-009770

CIK 0001876588other
View on SEC.govCompany Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 7:18 PM ET

Size

30.3 KB

Accession

0000899243-22-009770

Insider Transaction Report

Form 4
Period: 2022-03-01
ZimVie Inc.ZIMV
Whitney Rebecca Ann
See Remarks
Transactions
  • Award

    Common Stock

    2022-03-01+2,859→ 3,065 total
  • Award

    Common Stock

    2022-03-01+4,455→ 7,520 total
  • Award

    Stock Option (right to buy)

    2022-03-01+4,966→ 4,966 total
    Exercise: $20.49Exp: 2026-03-21→ Common Stock (4,966 underlying)
  • Award

    Stock Option (right to buy)

    2022-03-01+4,138→ 4,138 total
    Exercise: $20.70Exp: 2026-11-01→ Common Stock (4,138 underlying)
  • Award

    Stock Option (right to buy)

    2022-03-01+24,616→ 24,616 total
    Exercise: $24.01Exp: 2027-03-21→ Common Stock (24,616 underlying)
  • Award

    Stock Option (right to buy)

    2022-03-01+15,918→ 15,918 total
    Exercise: $22.45Exp: 2027-11-01→ Common Stock (15,918 underlying)
  • Award

    Stock Option (right to buy)

    2022-03-01+14,953→ 14,953 total
    Exercise: $23.56Exp: 2028-02-20→ Common Stock (14,953 underlying)
  • Award

    Stock Option (right to buy)

    2022-03-01+16,502→ 16,502 total
    Exercise: $22.54Exp: 2028-03-20→ Common Stock (16,502 underlying)
  • Award

    Stock Option (right to buy)

    2022-03-01+25,642→ 25,642 total
    Exercise: $24.37Exp: 2029-02-26→ Common Stock (25,642 underlying)
  • Award

    Stock Option (right to buy)

    2022-03-01+24,144→ 24,144 total
    Exercise: $31.03Exp: 2030-02-21→ Common Stock (24,144 underlying)
  • Award

    Stock Option (right to buy)

    2022-03-01+19,518→ 19,518 total
    Exercise: $32.26Exp: 2031-02-25→ Common Stock (19,518 underlying)
Footnotes (14)
  • [F1]On March 1, 2022, Zimmer Biomet Holdings, Inc. ("Zimmer Biomet") completed a pro rata spinoff distribution (the "Distribution") of shares of ZimVie Inc. ("ZimVie") common stock, par value $ 0.01 per share ("ZimVie Common Stock") to the holders of record of Zimmer Biomet common stock, par value $ 0.01 per share ("Zimmer Biomet Common Stock") on February 15, 2022. In connection with the Distribution, pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2022, between Zimmer Biomet and ZimVie (the "EMA"), all outstanding equity awards with respect to Zimmer Biomet Common Stock held by the Reporting Person were equitably adjusted and converted into equity awards with respect to ZimVie Common Stock, with such equitable adjustments determined based on (i) the volume weighted average trading price of Zimmer Biomet Common Stock on February 28, 2022 and (ii) the volume weighted average trading price of ZimVie common stock on March 1 through March 3, 2022.
  • [F10]This option vests ratably in four annual installments on the first four anniversaries of the grant date, February 20, 2018.
  • [F11]This option vests ratably in four annual installments on the first four anniversaries of the grant date, March 20, 2018.
  • [F12]This option vests ratably in four annual installments on the first four anniversaries of the grant date, February 26, 2019.
  • [F13]This option vests ratably in four annual installments on the first four anniversaries of the grant date, February 21, 2020.
  • [F14]This option vests ratably in four annual installments on the first four anniversaries of the grant date, February 25, 2021.
  • [F2]Represents the grant of restricted stock units with respect to ZimVie Common Stock ("ZimVie RSUs") upon the conversion of performance-based restricted stock units with respect to Zimmer Biomet Common Stock held by the Reporting Person as of March 1, 2022 in accordance with the terms of the EMA. The ZimVie RSUs vest on February 21, 2023.
  • [F3]Reflects 206 shares of ZimVie Common Stock received in the Distribution in respect of shares of Zimmer Biomet Common Stock held by the Reporting Person as of the record date for the Distribution.
  • [F4]Represents the grant of ZimVie RSUs upon the conversion of performance-based restricted stock units with respect to Zimmer Biomet Common Stock held by the Reporting Person as of March 1, 2022 in accordance with the terms of the EMA. The ZimVie RSUs vest on February 25, 2024.
  • [F5]Represents the grant of stock options to purchase ZimVie Common Stock upon the conversion of stock options to purchase Zimmer Biomet Common Stock in accordance with the terms of the EMA.
  • [F6]This option vests ratably in four annual installments on the first four anniversaries of the grant date, March 21, 2016.
  • [F7]This option vests ratably in four annual installments on the first four anniversaries of the grant date, November 1, 2016.
  • [F8]This option vests ratably in four annual installments on the first four anniversaries of the grant date, March 21, 2017.
  • [F9]This option vests ratably in four annual installments on the first four anniversaries of the grant date, November 1, 2017.

Documents

1 file

Issuer

ZimVie Inc.

CIK 0001876588

→
Entity typeother

Related Parties

1
  • filerCIK 0001406288

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 7:18 PM ET
Size
30.3 KB
View on SEC.gov